Latest technology reporting
Evidence-led coverage of biotechnology, AI infrastructure, energy, robotics, devices and brain–computer interfaces.
-
Kolibri’s Open Weights Make Sovereign AI a Concrete Infrastructure Choice
Aleph Alpha’s new German-English model can run on infrastructure its users control. Open weights expand that choice while leaving hardware and validation work.
-
Japan’s Chiba AI Plan Connects Computing Expansion to the LNG Supply Chain
JERA, Dell and RHAELM propose a repeatable power-to-compute model, starting at Chiba. The up-to-400 MW project targets operations around 2028.
-
Italy’s Cerignola Battery Shows Why Storage Needs Two Capacity Numbers
A 97 MW battery with 828 MWh of storage has a different role from a short-duration system. Cerignola illustrates the distinction while construction continues.
-
Google’s 3.59 GW Power Deal Targets 890 MW of New Nuclear Capacity
Google and Constellation have combined new reactor output with a larger existing-generation supply agreement. The distinction matters for the grid.
-
Five-Year Brain Organoids Open a Longer Window on Human Cell Development
Brain organoids grown for five years let researchers examine prolonged human development. Their maturity has to be measured, not inferred from survival.
-
Bird Genomes Expand an RNA Route for Inserting Genes Into Human Cells
A new study mined more than 1,100 bird genomes for R2 elements and engineered gene-insertion tools. The results come from cells in the laboratory.
-
A Phase III Lymphoma Result Moves Bispecific Antibodies Into the Frontline Debate
Epcoritamab plus R-CHOP reduced the risk of lymphoma progression or death in a Phase III trial. The full results and regulatory review still lie ahead.
-
Lambda’s Billion-Dollar GPU Loan Makes Customer Contracts Part of AI Infrastructure
A new fixed-rate facility will fund committed GPU deployments as they enter service. It shows how customer commitments are being used to finance the physical AI buildout.
-
Genentech’s Alector Deal Tests the Brain’s Enzyme Delivery Barrier
A new licence centres on getting a recycling enzyme into the brain. The Parkinson’s programme remains preclinical, and the biological rationale is not yet proof of benefit.
-
Poland’s 400 MW Battery Deal Makes Market Risk Part of the Storage Design
Statkraft and Greenvolt have agreed a ten-year arrangement for two Polish batteries. The development is about who manages electricity-market exposure, not a new chemistry.
-
Ageing Mouse Immune Cells Lose a Scaffold That Helps Organise DNA
A new study links declining SATB1 to altered genome folding in mouse T cells. It offers a mechanism to investigate, without demonstrating human rejuvenation.
-
AMD’s World Labs Deal Puts Spatial AI on the Chip Roadmap
The planned US$8.2 billion acquisition connects world-model research with a chipmaker. Interactive 3D generation is a concrete capability; dependable simulation remains a harder test.